Renhe Pharmacy Co.,Ltd

XSEC:000650 Stock Report

Market Cap: CN¥8.1b

Renhe PharmacyLtd Past Earnings Performance

Past criteria checks 2/6

Renhe PharmacyLtd has been growing earnings at an average annual rate of 0.8%, while the Pharmaceuticals industry saw earnings growing at 9.1% annually. Revenues have been growing at an average rate of 2.8% per year. Renhe PharmacyLtd's return on equity is 7.2%, and it has net margins of 10.1%.

Key information

0.8%

Earnings growth rate

-1.7%

EPS growth rate

Pharmaceuticals Industry Growth10.9%
Revenue growth rate2.8%
Return on equity7.2%
Net Margin10.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Renhe PharmacyLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSEC:000650 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 244,36444374540
30 Jun 244,71554876442
31 Mar 244,91456283345
31 Dec 235,03256780946
30 Sep 235,12665888240
30 Jun 235,27463189143
31 Mar 235,19860187744
01 Jan 235,15357487151
30 Sep 225,12259787449
30 Jun 225,14063487052
31 Mar 225,02966883655
01 Jan 224,93666585252
30 Sep 214,86472574256
30 Jun 214,68766980247
31 Mar 214,61463083143
31 Dec 204,27858080140
30 Sep 204,10047892439
30 Jun 204,07845693741
31 Mar 204,27349899537
31 Dec 194,5815381,06538
30 Sep 194,6225531,06232
30 Jun 194,5905861,02549
31 Mar 194,5495431,06835
31 Dec 184,4035061,06131
30 Sep 184,4655151,10731
30 Jun 184,3214631,08523
31 Mar 184,05940798429
31 Dec 173,84438089623
30 Sep 173,67936082217
30 Jun 173,6113578000
31 Mar 173,5573487590
31 Dec 163,5673727310
30 Sep 163,3243976550
30 Jun 163,0994036200
31 Mar 162,8584215930
31 Dec 152,5243915420
30 Sep 152,4513665880
30 Jun 152,4113416070
31 Mar 152,3463226090
31 Dec 142,2533015980
30 Sep 142,1142136120
30 Jun 141,9491695680
31 Mar 141,8121735230
31 Dec 131,7991945140

Quality Earnings: 000650 has high quality earnings.

Growing Profit Margin: 000650's current net profit margins (10.1%) are lower than last year (12.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 000650's earnings have grown by 0.8% per year over the past 5 years.

Accelerating Growth: 000650's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 000650 had negative earnings growth (-32.8%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-2.5%).


Return on Equity

High ROE: 000650's Return on Equity (7.2%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies